How much does the Dallas Pain Questionnaire score have to improve to indicate that patients with chronic low back pain feel better or well?

Purpose: The Dallas Pain Questionnaire (DPQ) assesses the impact of low back pain (LBP) on four components (0-100) of daily life. We estimated the minimal clinically important improvement (MCII) and the patient acceptable symptom state (PASS) values of DPQ in LBP patients.

Methods: 142 patients with LBP lasting for at least 4 weeks completed a battery of questionnaires at baseline and 6 months later. Questions for MCII addressed patient-reported response to treatment at 6 months on a five-point Likert scale, while a yes/no question concerning satisfaction with present state was used to determine PASS. MCII was computed as the difference in mean DPQ scores between patients reporting treatment as effective vs. patients reporting treatment as not effective, and PASS was computed as the third quartile of the DPQ score among patients who reported being satisfied with their present state.

Results: MCII values were 22, 23, 2 and 10 for daily activities, work and leisure, social interest, and anxiety/depression, respectively. PASS values were 29, 23, 20 and 21 for the four components, respectively. The PASS total score threshold of 24 correctly classified 84.1 % of the patients who reported being unsatisfied with their present state, and 74.7 % of patients reported being satisfied.

Conclusions: These values give information of paramount importance for clinicians in interpreting change in DPQ values over time. Authors should be encouraged to report the percentage of patients who reach MCII and PASS values in randomized clinical trials and cohort studies to help clinicians to interpret clinical results.

Keywords: Dallas Pain Questionnaire; Low back pain; Minimal clinically important change; Outcome measures; Patient acceptable stable state.

Similar articles

Haas M, Jacobs GE, Raphael R, Petzing K. Haas M, et al. J Manipulative Physiol Ther. 1995 Feb;18(2):79-87. J Manipulative Physiol Ther. 1995. PMID: 7790787

Chapman JR, Norvell DC, Hermsmeyer JT, Bransford RJ, DeVine J, McGirt MJ, Lee MJ. Chapman JR, et al. Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S54-68. doi: 10.1097/BRS.0b013e31822ef74d. Spine (Phila Pa 1976). 2011. PMID: 21952190 Review.

Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, Felson DT, Hajjaj-Hassouni N, Hochberg M, Logeart I, Matucci-Cerinic M, van de Laar M, van der Heijde D, Dougados M. Tubach F, et al. Arthritis Care Res (Hoboken). 2012 Nov;64(11):1699-707. doi: 10.1002/acr.21747. Arthritis Care Res (Hoboken). 2012. PMID: 22674853

Lapin B, Davin S, Stilphen M, Benzel E, Katzan IL. Lapin B, et al. Spine (Phila Pa 1976). 2020 Feb 15;45(4):E227-E235. doi: 10.1097/BRS.0000000000003232. Spine (Phila Pa 1976). 2020. PMID: 31513107

Coulombe BJ, Games KE, Neil ER, Eberman LE. Coulombe BJ, et al. J Athl Train. 2017 Jan;52(1):71-72. doi: 10.4085/1062-6050-51.11.16. Epub 2016 Nov 16. J Athl Train. 2017. PMID: 27849389 Free PMC article. Review.

Cited by

Ahadi T, Raissi GR, Hosseini M, Sajadi S, Ebadi S, Mansoori K. Ahadi T, et al. Basic Clin Neurosci. 2020 Nov-Dec;11(6):753-763. doi: 10.32598/bcn.11.6.1553.1. Epub 2020 Nov 1. Basic Clin Neurosci. 2020. PMID: 33850612 Free PMC article.

References

    1. J Rheumatol. 2001 Feb;28(2):431-8 - PubMed
    1. Best Pract Res Clin Rheumatol. 2005 Aug;19(4):593-607 - PubMed
    1. J Rheumatol. 2005 Oct;32(10):2025-9 - PubMed
    1. Spine (Phila Pa 1976). 2006 Mar 1;31(5):578-82 - PubMed
    1. J Clin Epidemiol. 2007 Jan;60(1):34-42 - PubMed